SIEGALL CLAY B

Average Profitability
<0.0001%
Insider Buys Quantity
5
Insider Buys Sum
$3.35M
Insider Sells Quantity
2
Insider Sells Sum
$2.14M

Insider Activity of SIEGALL CLAY B

According to the SEC Form 4 filings, SIEGALL CLAY B, being in a position of

  1. President and CEO at Immunome, Inc.,
    оver the last 12 months, has bought 200000 shares for $2.35M, and sold 0 shares,
    over all time since 2023-10-02, has bought 369204 shares for $3.35M, and sold 0 shares.

The largest purchase of all time was on 2024-05-20 and amounted to 79566 shares of Immunome, Inc. for $1.11M.

The largest sale of all time was on 2020-08-07 and amounted to 23404 shares of Ultragenyx Pharmaceutical Inc. for $2M.

Biography of SIEGALL CLAY B

No biography is available at this moment.

2024-11-22PurchaseImmunome, Inc.
IMNM
President and CEO
33,943
0.0543%
$9.78$331,918+35.13%
2024-11-21PurchaseImmunome, Inc.
IMNM
President and CEO
66,057
0.1059%
$9.54$630,263+38.75%
2024-05-21PurchaseImmunome, Inc.
IMNM
President and CEO
20,434
0.0344%
$13.78$281,548-0.77%
2024-05-20PurchaseImmunome, Inc.
IMNM
President and CEO
79,566
0.1337%
$13.91$1.11M-2.17%
2023-10-02PurchaseImmunome, Inc.
IMNM
President and CEO
169,204
0.9994%
$5.91$999,996+76.83%
2020-08-10SaleUltragenyx Pharmaceutical Inc.
RARE
director
1,596
0.0026%
$85.01$135,676+25.25%
2020-08-07SaleUltragenyx Pharmaceutical Inc.
RARE
director
23,404
0.0389%
$85.55$2M+25.78%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.